Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Bought by Nuveen Asset Management LLC

Nuveen Asset Management LLC lifted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 47.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 560,637 shares of the company's stock after acquiring an additional 181,676 shares during the period. Nuveen Asset Management LLC owned approximately 0.60% of Acadia Healthcare worth $22,229,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in ACHC. JPMorgan Chase & Co. boosted its holdings in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. Nisa Investment Advisors LLC grew its position in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after buying an additional 301 shares in the last quarter. SG Americas Securities LLC increased its stake in Acadia Healthcare by 713.3% in the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock worth $4,396,000 after acquiring an additional 97,235 shares during the last quarter. Inspire Investing LLC raised its holdings in shares of Acadia Healthcare by 54.2% in the 4th quarter. Inspire Investing LLC now owns 10,249 shares of the company's stock valued at $406,000 after acquiring an additional 3,602 shares in the last quarter. Finally, Fifth Third Bancorp grew its holdings in shares of Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after purchasing an additional 454 shares in the last quarter.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Mizuho lowered their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Barclays lowered their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a report on Wednesday, May 14th. Bank of America lowered their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. KeyCorp cut their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Finally, Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Four analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $47.94.

Acadia Healthcare Stock Performance

ACHC traded down $0.72 on Wednesday, reaching $22.81. 593,626 shares of the stock were exchanged, compared to its average volume of 1,716,258. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market capitalization of $2.10 billion, a PE ratio of 7.48, a PEG ratio of 1.46 and a beta of 1.01. The company's 50-day moving average price is $25.45 and its 200 day moving average price is $34.64.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's revenue for the quarter was up .3% compared to the same quarter last year. During the same period last year, the firm posted $0.84 EPS. As a group, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.